Skip to main content Back to Top

A New Landscape: Biosimilars in Multiple Sclerosis

September 22, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Learn from experts in the field on Multiple Sclerosis.



Aimee BanksAimee M. Banks, PharmD, BCPS, MSCS is a certified Multiple Sclerosis (MS) clinical pharmacist at Vanderbilt University Medical Center. She graduated from The University of Tennessee College of Pharmacy and completed a PGY-1 pharmacy practice residency at the Veterans Affairs Medical Center in Memphis. Aimee moved to Nashville and joined the Vanderbilt Specialty Pharmacy in 2013. At that time, she piloted specialty pharmacy services in the Comprehensive MS Center, where she continues to serve patients and manage their clinical and specialty pharmacy needs. As a pharmacist integrated full-time in the MS clinic, Aimee has the unique opportunity to work alongside physicians, nurses, social workers, researchers, and other members of the comprehensive care team. This collaborative practice method allows for efficient and coordinated care for patients with MS at Vanderbilt. As a thought leader and subject matter expert in both MS care and specialty pharmacy services, Aimee has been heavily involved with various committees, focus groups, and educational programs throughout her 10 years at Vanderbilt.

Jorge GarciaJorge Garcia, PharmD, MS, MHA, MBA, FACHE obtained his Doctor of Pharmacy and Master of Business Administration from Nova Southeastern University (NSU) in 2010. He then transitioned to the University of Pittsburgh Medical Center (UPMC) to pursue an American Society of Health-System Pharmacy (ASHP)-accredited PGY-1 & PGY-2 Health-System Pharmacy Administration Residency and a Master of Science in Pharmacy Administration. He also completed an Master of Healthcare Administration from Florida Atlantic University (FAU). Dr. García has previously served in the roles of inpatient pharmacy operations coordinator as well as director of pharmacy for system-wide oncology pharmacy services.


Relevant Financial Relationship Disclosures

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.


Biosimilar Adoption: Past Experiences and Future Opportunities

Biosimilar Adoption Breaking through Barriers Resource Center

More in this Series

A New Landscape: Biosimilars in Autoimmune Indications


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is provided by ASHP and sponsored in part by Amgen. Supported in part by an independent medical education grant from Sandoz Inc., a Novartis Division.